ISSN: 2041-6792

Clinical Investigation

Age Related Macular Degeneration Journals

Age-related macular degeneration (AMD) in adults over 50 years of age is the leading cause of severe vision loss. The Centers for Disease Control and Prevention estimates that 1.8 million people have AMD and another 7.3 million people are at significant risk of AMD vision loss. Caucasians have a higher risk of developing AMD compared with other races. Women develop AMD at a younger age than men too. This eye disease occurs when the macula, a small portion of the retina that is located on the eye's inner back layer, changes. AMD is a central vision loss, which can occur in two forms: dry (atrophic) and wet (exudative). The dry form is in most people with macular degeneration. While there is no specific treatment for dry AMD, studies have revealed a potential benefit from Mediterranean diet vitamin supplements and smoking cessation. If detected and treated early, the less common wet form could respond to intraocular injections of anti-VEGF medications. Journals on age related macular degeneration focus on research and review articles of the same.

High Impact List of Articles

Relevant Topics in Clinical